In Friday’s list of the IBD 50, 12 of the top 15 names stood extended too far in price. In fact, one of the top 15, Synchronoss Technologies (SNCR), has risen so much that it triggered the rule to sell at least some shares when the gain from a proper buy point reaches 20% to 25%. Monday’s list does not show much change to that end. A stock that is extended means the stock is not at a proper entry point.